De La Rosa Abel 4
4 · Virios Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
De La Rosa Abel
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-15+5,250→ 5,250 totalExercise: $1.85Exp: 2033-06-15→ Common Stock (5,250 underlying)
Footnotes (1)
- [F1]The stock option will vest 100% on June 15, 2024, one year following the grant date.